Trial Profile
A Phase III trial of Human Fibrinogen
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Oct 2017
Price :
$35
*
At a glance
- Drugs Fibrinogen (Primary)
- Indications Afibrinogenaemia
- Focus Therapeutic Use
- 12 Oct 2017 New trial record
- 09 Oct 2017 According to a China Biologic Products media release, the company has received approval to begin Phase III clinical trials for Fibrinogen in 2012.